• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

经皮冠状动脉介入治疗在原发性动脉与先前冠状动脉旁路移植术患者中的旁路移植术:来自国家心血管数据注册中心的报告。

Percutaneous coronary intervention in native arteries versus bypass grafts in prior coronary artery bypass grafting patients: a report from the National Cardiovascular Data Registry.

机构信息

VA North Texas Healthcare System and University of Texas Southwestern Medical School at Dallas, Dallas, Texas, USA.

出版信息

JACC Cardiovasc Interv. 2011 Aug;4(8):844-50. doi: 10.1016/j.jcin.2011.03.018.

DOI:10.1016/j.jcin.2011.03.018
PMID:21851896
Abstract

OBJECTIVES

This study examined a large registry to determine the frequency, predictors, and outcomes of native coronary artery versus bypass graft percutaneous coronary intervention (PCI) in patients with prior coronary artery bypass graft surgery (CABG).

BACKGROUND

The PCI target vessel and corresponding outcomes in prior CABG patients are poorly studied.

METHODS

We analyzed the frequency and factors associated with native versus bypass graft PCI in prior CABG patients undergoing PCI between January 1, 2004, and June 30, 2009, in the National Cardiovascular Data Registry (NCDR) CathPCI Registry. Generalized estimating equations logistic regression modeling was used to generate independent variables associated with native versus bypass graft PCI and in-hospital mortality.

RESULTS

During the study period, PCI in prior CABG patients represented 17.5% of the total PCI volume (300,902 of 1,721,046). The PCI target was a native coronary artery in 62.5% and a bypass graft in 37.5%: saphenous vein graft (SVG) (104,678 [34.9%]), arterial graft (7,517 [2.5%]), or both arterial graft and SVG (718 [0.2%]). Compared with patients undergoing native coronary artery PCI, those undergoing bypass graft PCI had higher-risk characteristics and more procedural complications. On multivariable analysis, several parameters (including graft stenosis and longer interval from CABG) were associated with performing native coronary PCI, and bypass graft PCI was associated with higher in-hospital mortality (adjusted odds ratio: 1.22, 95% confidence interval: 1.12 to 1.32).

CONCLUSIONS

Most PCIs performed in prior CABG patients are done in native coronary artery lesions. Compared with native coronary PCI, bypass graft PCI is independently associated with higher in-hospital mortality.

摘要

目的

本研究通过一项大型注册研究,旨在确定既往接受冠状动脉旁路移植术(CABG)的患者行冠状动脉原位或旁路移植血管经皮冠状动脉介入治疗(PCI)的频率、预测因素和结局。

背景

既往 CABG 患者 PCI 的靶血管及相应结局研究甚少。

方法

我们分析了 2004 年 1 月 1 日至 2009 年 6 月 30 日期间在国家心血管数据注册(NCDR) CathPCI 注册中心接受 PCI 的既往 CABG 患者中,行冠状动脉原位或旁路移植血管 PCI 的频率和相关因素。采用广义估计方程逻辑回归模型生成与行冠状动脉原位或旁路移植血管 PCI 相关的独立变量,并分析院内死亡率。

结果

在研究期间,既往 CABG 患者的 PCI 占总 PCI 量的 17.5%(300902 例,占 1721046 例的 17.5%)。PCI 的靶血管为冠状动脉原位者占 62.5%,旁路移植血管者占 37.5%:大隐静脉桥(SVG)(104678 例[34.9%])、动脉桥(7517 例[2.5%])或两者均有(718 例[0.2%])。与行冠状动脉原位 PCI 的患者相比,行旁路移植血管 PCI 的患者具有更高危的特征和更多的手术并发症。多变量分析显示,包括桥血管狭窄和 CABG 后时间间隔较长等几个参数与行冠状动脉原位 PCI 相关,而旁路移植血管 PCI 与更高的院内死亡率相关(校正比值比:1.22,95%置信区间:1.12 至 1.32)。

结论

既往 CABG 患者中进行的大多数 PCI 都是在冠状动脉原位病变中进行的。与冠状动脉原位 PCI 相比,旁路移植血管 PCI 独立与更高的院内死亡率相关。

相似文献

1
Percutaneous coronary intervention in native arteries versus bypass grafts in prior coronary artery bypass grafting patients: a report from the National Cardiovascular Data Registry.经皮冠状动脉介入治疗在原发性动脉与先前冠状动脉旁路移植术患者中的旁路移植术:来自国家心血管数据注册中心的报告。
JACC Cardiovasc Interv. 2011 Aug;4(8):844-50. doi: 10.1016/j.jcin.2011.03.018.
2
Frequency and predictors of drug-eluting stent use in saphenous vein bypass graft percutaneous coronary interventions: a report from the American College of Cardiology National Cardiovascular Data CathPCI registry.药物洗脱支架在冠状动脉旁路移植术经皮冠状动脉介入治疗中的应用频率及预测因素:美国心脏病学会国家心血管数据经皮冠状动脉介入治疗登记报告。
JACC Cardiovasc Interv. 2010 Oct;3(10):1068-73. doi: 10.1016/j.jcin.2010.07.009.
3
Percutaneous Coronary Intervention in Native Coronary Arteries Versus Bypass Grafts in Patients With Prior Coronary Artery Bypass Graft Surgery: Insights From the Veterans Affairs Clinical Assessment, Reporting, and Tracking Program.经皮冠状动脉介入治疗在既往冠状动脉旁路移植术患者中的应用:来自退伍军人事务部临床评估、报告和跟踪计划的见解。
JACC Cardiovasc Interv. 2016 May 9;9(9):884-93. doi: 10.1016/j.jcin.2016.01.034. Epub 2016 Apr 13.
4
Comparison of percutaneous coronary intervention in native coronary arteries vs. bypass grafts in patients with prior coronary artery bypass graft surgery.既往接受冠状动脉旁路移植术患者的自身冠状动脉与旁路移植血管行经皮冠状动脉介入治疗的比较。
Cardiovasc Revasc Med. 2009 Apr-Jun;10(2):103-9. doi: 10.1016/j.carrev.2008.12.002.
5
Drug-eluting stents and the use of percutaneous coronary intervention among patients with class I indications for coronary artery bypass surgery undergoing index revascularization: analysis from the NCDR (National Cardiovascular Data Registry).药物洗脱支架与接受首次血运重建的冠状动脉旁路移植术I类适应症患者经皮冠状动脉介入治疗的应用:来自国家心血管数据注册库(NCDR)的分析
JACC Cardiovasc Interv. 2009 Jul;2(7):614-21. doi: 10.1016/j.jcin.2009.05.001.
6
Does prior percutaneous coronary intervention adversely affect early and mid-term survival after coronary artery surgery?既往经皮冠状动脉介入治疗是否会对冠状动脉搭桥术后的早期和中期生存产生不利影响?
JACC Cardiovasc Interv. 2009 Aug;2(8):758-64. doi: 10.1016/j.jcin.2009.04.018.
7
Outcomes of patients with acute myocardial infarction from a saphenous vein graft culprit undergoing percutaneous coronary intervention.经皮冠状动脉介入治疗的隐静脉桥罪犯病变急性心肌梗死患者的结局。
Catheter Cardiovasc Interv. 2011 Jul 1;78(1):23-9. doi: 10.1002/ccd.22873. Epub 2011 Mar 16.
8
Outcomes after implantation of the TAXUS paclitaxel-eluting stent in saphenous vein graft lesions: results from the ARRIVE (TAXUS Peri-Approval Registry: A Multicenter Safety Surveillance) program.紫杉醇洗脱支架在静脉桥病变中的应用结果:ARRIVE(TAXUS 批准前注册:多中心安全性监测)研究结果。
JACC Cardiovasc Interv. 2010 Jul;3(7):742-50. doi: 10.1016/j.jcin.2010.04.012.
9
Risk profile and 3-year outcomes from the SYNTAX percutaneous coronary intervention and coronary artery bypass grafting nested registries.SYNTAX 经皮冠状动脉介入治疗和冠状动脉旁路移植术嵌套注册研究的风险特征和 3 年结果。
JACC Cardiovasc Interv. 2012 Jun;5(6):618-25. doi: 10.1016/j.jcin.2012.02.013.
10
In-hospital and 1-year outcomes with drug-eluting versus bare metal stents in saphenous vein graft intervention: a report from the EVENT registry.药物洗脱支架与金属裸支架在静脉桥血管介入治疗中的院内和 1 年预后:来自 EVENT 注册研究的报告。
Catheter Cardiovasc Interv. 2012 Dec 1;80(7):1127-36. doi: 10.1002/ccd.24352. Epub 2012 May 4.

引用本文的文献

1
Incidence and Characteristics of ST-Elevation Myocardial Infarction in Patients With Previous Coronary Artery Bypass Grafting: A Single-Center Experience.既往冠状动脉旁路移植术患者ST段抬高型心肌梗死的发病率及特征:一项单中心经验
Cureus. 2025 Jun 29;17(6):e86978. doi: 10.7759/cureus.86978. eCollection 2025 Jun.
2
Robotic-Assisted Redo Coronary Artery Bypass Grafting: A Single-Center Experience.机器人辅助再次冠状动脉旁路移植术:单中心经验
Ann Thorac Cardiovasc Surg. 2025;31(1). doi: 10.5761/atcs.oa.25-00026.
3
Outcome of Saphenous Vein Graft Percutaneous Coronary Intervention Using Contemporary Drug-Eluting Stents: A SCAAR Report.
使用当代药物洗脱支架行大隐静脉移植血管经皮冠状动脉介入治疗的结果:一项瑞典冠状动脉血管造影和血管成形术注册研究报告
J Soc Cardiovasc Angiogr Interv. 2024 Sep 26;3(10):102232. doi: 10.1016/j.jscai.2024.102232. eCollection 2024 Oct.
4
Defining Key Features of Complex Coronary Lesions: An Evidence Based Review of Clinical Practice. Part II: Chronic Total Occlusions, Graft Interventions, In-Stent Restenosis, and Antithrombotic Strategies.定义复杂冠状动脉病变的关键特征:基于证据的临床实践综述。第二部分:慢性完全闭塞病变、移植血管介入治疗、支架内再狭窄及抗栓策略。
Rev Cardiovasc Med. 2022 Jun 8;23(6):209. doi: 10.31083/j.rcm2306209. eCollection 2022 Jun.
5
Percutaneous Coronary Intervention of Native Artery Versus Bypass Graft in Patients with Prior Coronary Artery Bypass Graft Surgery.冠状动脉旁路移植术后患者行冠状动脉介入治疗:自体血管与移植血管的比较
Rev Cardiovasc Med. 2022 Jun 24;23(7):232. doi: 10.31083/j.rcm2307232. eCollection 2022 Jul.
6
Brazilian Guideline for Exercise Test in the Adult Population - 2024.《巴西成人运动测试指南 - 2024》
Arq Bras Cardiol. 2024 Feb;121(3):e20240110. doi: 10.36660/abc.20240110.
7
Single-Centre Registry Analysis of Patients Who Underwent Percutaneous Coronary Intervention on Their Coronary Bypass Grafts.冠状动脉旁路移植术后接受经皮冠状动脉介入治疗患者的单中心注册研究分析
CJC Open. 2023 Nov 10;6(3):548-555. doi: 10.1016/j.cjco.2023.11.005. eCollection 2024 Mar.
8
Long-term results of percutaneous coronary intervention in no-touch vein grafts are significantly better than in conventional vein grafts.非接触式静脉移植物经皮冠状动脉介入治疗的长期效果明显优于传统静脉移植物。
Perfusion. 2025 Jan;40(1):211-220. doi: 10.1177/02676591241230012. Epub 2024 Jan 22.
9
Evidence-based Management of Left Main Coronary Artery Disease.左主干冠状动脉疾病的循证管理
Eur Cardiol. 2023 Dec 19;18:e63. doi: 10.15420/ecr.2023.36. eCollection 2023.
10
Saphenous Vein Graft Failure: Current Challenges and a Review of the Contemporary Percutaneous Options for Management.大隐静脉移植血管失败:当前挑战及当代经皮治疗选择综述
J Clin Med. 2023 Nov 15;12(22):7118. doi: 10.3390/jcm12227118.